Use of biperiden

PDMED_BIPERIDEN

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04AA02

2669

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1578

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1578

diagram downward connector

Include endpoints None

1578

diagram downward connector
PDMED_BIPERIDEN

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 1527 759 768
Unadjusted prevalence (%) 0.49 0.44 0.57
Mean age at first event (years) 43.74 42.63 44.83

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.18 [1.40, 3.38] 5.2e-4 164
15 years 0.01 1.42 [0.95, 2.12] 8.4e-2 71
5 years 0.00 2.24 [1.48, 3.38] 1.3e-4 33
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_BIPERIDEN – Use of biperiden
GWS hits:

Survival analyses between endpoints

Plot

before Use of biperiden
after Use of biperiden

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of biperiden